Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Lloyds cohort shows insurtechs still looking to innovate while start-ups and deals see 80% fall in 2020, says GlobalData

Lloyds’s Lab insurtech cohort both continuing and actively focusing on pandemic solutions is undoubtedly a positive for the insurance industry. Lloyds Lab is one of the most prestigious incubators for insurance start-ups in the insurance sector, and is essential in an environment where start-up and deals are significantly down so far in 2020 – with […]
Read more

UK’s plans for significant revisions to outbreak control agencies has questionable timing amid 40,000 death toll, says GlobalData

Following the news that UK Health Secretary Matt Hancock has announced National Institution for Health Protection; Michael Breen, Director of Infectious Diseases at GlobalData, offers his view: “The COVID-19 pandemic has exposed both global and national inefficiencies in responding to the COVID-19 outbreak, and, in light of an estimate that there has been 40,000 deaths […]
Read more

Sentimental recovery in food services sector driven by Del Taco and Yum! Brands benefitted by quick implementation of digital infrastructure, says GlobalData

In July 2020, ten of the top 11 global foodservice companies witnessed a recovery in their earnings transcript sentiment score. Sentiment growth in the sector was largely driven by Del Taco Restaurants, which saw over 30% in July 2020*, compared to Q1 2020, according to GlobalData, a leading data, and analytics company. Rinaldo Pereira, Senior […]
Read more

Colombia boasts a strong solar PV and wind push to reduce dependence from vulnerable hydro generation to a resilient green generation mix, says GlobalData

Reviewing its activities in the wake of the country’s Energy and Mining Transition, the  Colombian Government has diverted its focus on expanding its solar PV and wind installed capacity through auction and non auction mechnisms. The nation relies heavily on hydropower generation, which has become increasingly vulnerable to weather variability – specifically the hot and […]
Read more

Israel’s continued reliance on gas power generation may jeopardize efforts to achieve carbon neutrality by mid century, says GlobalData

The Organization for Economic Co-operation and Development’s (OECD’s) Environment Directorate specified that creating an electricity framework based on natural gas will threaten decarbonization objectives due to the lock-in period in carbon-intensive infrastructure. Continued reliance on gas-based generation in  Israel is expected to diminish the country’s efforts in mitigating carbon emissions, says GlobalData, a leading data […]
Read more

Facebook recalibrating focus to financial services with Novi and Jio; hires cautiously, finds GlobalData

Facebook’s job postings plunged drastically from 1,102 in January to 551 in July, according to GlobalData’s job analytics database, likely attributed to challenging market conditions due to the COVID-19 outbreak. However, there have been some notable senior-level job postings in advertising, e-commerce and payments space in recent months. Aurojyoti Bose, Lead Analyst at GlobalData, says: […]
Read more

Growth of wind and solar PV to compliment Sweden’s hydropower to achieve 100% RE generation target by 2040, says GlobalData

Taking advantage of government incentives and declining costs, the share of wind and solar energy combined have reached almost 14% in Sweden’s generation mix. While the country’s solar PV sector is still in a nascent stage, GlobalData notes that rising support from the Swedish Government and the country’s push towards clean energy are expected to […]
Read more

COVID-19 disrupted clinical trials with suspended enrollment more likely to resume, says GlobalData

The number of total disrupted clinical trials has begun to fall since June, however, only trials that suspended enrollment have been on a downward trajectory, says GlobalData, a leading data and analytics company. Brooke Wilson, Associate Director, Trials Intelligence at GlobalData, comments: “Trials that had already initiated enrollment before the pandemic – having already chosen […]
Read more

COVID-19 is causing lower flu vaccination rates in the UK, says GlobalData

The UK has one of the highest flu vaccination rates in the world. However, the COVID-19 pandemic is increasing appointment times due to extra precautions needing to be taken to avoid COVID-19 contamination and reducing patients’ access to healthcare over fear of catching the disease. Therefore, despite the importance of vaccination during the pandemic, GlobalData […]
Read more

Changes to coverage policies for ventricular assist devices will impact heart failure device market, says GlobalData

The Centers for Medicare & Medicaid Services (CMS) in the US has issued a statement indicating their proposal to increase access to ventricular access devices (VADs) for patients living with severe heart conditions, including a specific update to the criteria for treatment with a Total Artificial Heart (TAH). Leading data and analystics company GlobalData expects […]
Read more

SME broker channel boosted by Aviva BI payouts, says GlobalData

Despite claiming it had policy wordings excluding pandemics in 95% of its policies, Aviva announced that it has had to pay out business interruption claims that came through brokers, which didn’t necessarily carry over the exclusion. This will be a relief to many businesses and potentially offer a boost to the broker channel in terms […]
Read more

Wearable tech market set to grow 137% by 2024 but smartwatches to see a 10% decline in revenue this year due to shipment delays and tighter consumer wallets, says GlobalData

Wearables have seen significant growth in the medical market over the past several years due to their potential to address spiraling healthcare costs, aging populations, and the burden of chronic disease. According to GlobalData, the wearable tech market was worth nearly $27bn in 2019 and is likely to grow to $64bn by 2024 due to […]
Read more

Opdivo to replace Herceptin as the distinguished leader in gastric and gastro-oesophageal cancer following label expansions, says GlobalData

Opdivo is set to become the market leader in gastric in gastro-oesophageal cancer following the latest data from two label expansion trials, which were noted to have met their primary endpoints. GlobalData expects Opdivo’s label expansions to gain approval in mid-2021 and revolutionize this indication as the first targeted therapy available in the adjuvant setting […]
Read more

Guardant Health expected to see continued revenue as EGFR test a much-needed boon for NSCLC space, says GlobalData

Following the FDA’s approval of Guardant Health’s liquid biopsy comprehensive tumor mutation profiling across all solid cancers; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “This is a landmark approval for cancer testing as Guardant Health’s liquid biopsy is the first of its kind to genetically profile […]
Read more
1 … 40 41 42 43 44 … 77